Clinical Trial Update: NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neuroprotection with CoQ10 and GPI-1485 in Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CoQ10 (coenzyme Q10)
• GPI-1485

Snippet

Sponsor: University of Rochester | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED